Label Changes for:

Viibryd (Vilazodone HCL) Tablets

December 2012

Changes have been made to the CONTRAINDICATIONS, WARNINGS and PRECAUTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – December 2012

 

(Serotonin Toxicity associated with co-administration with Linezolid and Methylene Blue)
Hide
(web3)